An immunotherapy turbocharger?; New targets for diabetes, antivenom, chemo resistance;

> New research from the Francis Crick Institute indicates that adding aspirin could turbocharge immunotherapies. Release

> A study at the University of Iowa points to the mitochondrial pyruvate carrier as critical for controlling glucose production in the liver, making it a potential new diabetes drug target. Release

> Investigators at Imperial College London are studying a new therapy that they believe has great potential for preventing motion sickness. Release

> An international group of scientists believe they are on track to developing a less expensive antivenom treatment. Release

> Investigators at UC San Diego say they have found a new pathway and drug that could be used to prevent resistance to chemotherapy and radiation. Release